D. Banker

发表

Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.

M. Groudine, F. Appelbaum, C. Willman, 1998, Leukemia research.

Measurement of Spontaneous and Therapeutic Agent-Induced Apoptosis With BCL-2 Protein Expression in Acute Myeloid Leukemia

M. Groudine, F. Appelbaum, D. Banker, 1997 .

Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.

F. Appelbaum, C. Willman, D. Banker, 2001, Leukemia research.

Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses.

F. Appelbaum, C. Willman, D. Banker, 2003, Blood.

HeLa cell mutants resistant to epidermal growth factor ricin A‐chain conjugate

D. Banker, H. Herschman, 1989, Journal of cellular physiology.

Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells.

F. Appelbaum, C. Willman, D. Banker, 2004, Blood.

Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression.

F. Appelbaum, C. Willman, D. Banker, 2003, Leukemia research.

Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.

F. Appelbaum, C. Willman, D. Banker, 2000, Cytometry.

An epidermal growth factor‐ricin a chain (EGF‐RTA)‐resistant mutant and an epidermal growth factor‐Pseudomonas endotoxin (EGF‐PE)‐resistant mutant have distinct phenotypes

I. Pastan, M. Gottesman, D. Banker, 1989, Journal of cellular physiology.

Toxicity of ligand and antibody‐directed ricin A‐chain conjugates recognizing the epidermal growth factor receptor

A. Vollmar, J. Mendelsohn, D. Banker, 1987, Journal of cellular physiology.

The thyroid hormone receptor gene (c-erbA alpha) is expressed in advance of thyroid gland maturation during the early embryonic development of Xenopus laevis

R. Eisenman, D. Banker, J. Bigler, 1991, Molecular and cellular biology.

The Thyroid Hormone Receptor Gene (c-erbAo) Is Expressed in Advance of Thyroid Gland Maturation during the Early Embryonic Development of Xenopus laevis

R. Eisenman, D. Banker, J. Bigler, 2022 .

Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.

M. Groudine, F. Appelbaum, D. Banker, 1997, Blood.

The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults.

J. Radich, F. Appelbaum, C. Willman, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML

M. Bar, P. Greenberg, D. Banker, 2016 .

Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).

F. Appelbaum, C. Willman, D. Banker, 2001, Experimental hematology.

Immortalization in a normal foreskin fibroblast culture following transduction of cyclin A2 or cdk1 genes in retroviral vectors.

M. Gray, D. Banker, T. Norwood, 2004, Experimental cell research.

Mitochondria and apoptosis: new therapeutic targets.

D. Banker, D. Hockenbery, J. O'neill, 2002, Advances in cancer research.

PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism.

F. Appelbaum, D. Banker, M. Cronk, 2005, Blood.

PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism.

F. Appelbaum, D. Fennell, C. Willman, 2002, Leukemia research.

Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis.

P. Rabinovitch, D. Banker, J. Glogovac, 1996, Cytometry.

The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.

I. Bernstein, F. Appelbaum, D. Banker, 2004, Blood.

ozogamicin different resistance mechanisms to sensitize AML cells to gemtuzumab The peripheral benzodiazepine receptor ligand PK11195 overcomes

I. Bernstein, F. Appelbaum, D. Banker, 2013 .

Thyroid hormone receptor can modulate retinoic acid-mediated axis formation in frog embryogenesis

R. Eisenman, D. Banker, 1993, Molecular and cellular biology.

Increments in Acute Myeloid Leukemia Cells Cholesterol Synthesis and Import Contribute to Protective Cholesterol

F. Appelbaum, C. Willman, D. Banker, 2013 .

Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study.

E. Estey, Z. Estrov, F. Appelbaum, 2005, Blood.